학술논문

Characterisation of Familial Colorectal Cancer Type X, Lynch syndrome, and non-familial colorectal cancer.
Document Type
Article
Source
British Journal of Cancer. 7/29/2014, Vol. 111 Issue 3, p598-602. 5p. 2 Charts.
Subject
*COLON cancer diagnosis
*COLON cancer risk factors
*COLON cancer treatment
*HEREDITARY nonpolyposis colorectal cancer
*LYMPHOCYTES
Language
ISSN
0007-0920
Abstract
Background:Familial Colorectal Cancer Type X (FCCTX) is defined as individuals with colorectal cancer (CRC) who families meet Amsterdam Criteria-1 (AC1), but whose tumours are DNA-mismatch-repair-proficient, unlike Lynch syndrome (LS). FCCTX does not have an increased risk of extra-colonic cancers. This analysis compares epidemiologic and clinicopathologic features among FCCTX, LS, and 'non-familial' (non-AC1) CRC cases.Methods:From the Colon Cancer Family Registry, FCCTX (n=173), LS (n=303), and non-AC1 (n=9603) CRC cases were identified. Questionnaire-based epidemiologic information and CRC pathologic features were compared across case groups using polytomous logistic regression.Results:Compared with LS, FCCTX cases were less likely to be current (vs never) smokers; have a proximal subsite (vs rectal) tumour; or have mucinous histology, poor differentiation, or tumour-infiltrating lymphocytes. There were no observed differences in co-morbidities or medication usage.Conclusions:FCCTX were less likely to be current tobacco users; other exposures were similar between these groups. Histopathologic differences highly suggestive of LS CRCs do not appear to be shared by FCCTX. [ABSTRACT FROM AUTHOR]